Showing results (2611-2620 of 3,712) with videos related to
Sort By:
Pageof 372
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012Genevieve M Klug, Alison Boyd, Teresa Zhao, et al.Physical Review Letters|May 7, 2016
Topological Optical Waveguiding in Silicon and the Transition between Topological and Trivial Defect StatesAndrea Blanco-Redondo, Imanol Andonegui, Matthew J Collins, et al.The International Journal of Cardiovascular Imaging|March 17, 2017
Comprehensive 4-stage categorization of bicuspid aortic valve leaflet morphology by cardiac MRI in 386 patientsI G Murphy, J Collins, A Powell, et al.Osteoarthritis and Cartilage|March 7, 2017
Instruments assessing attitudes toward or capability regarding self-management of osteoarthritis: a systematic review of measurement propertiesJ P Eyles, D J Hunter, S R F Meneses, et al.Communicable Diseases Intelligence Quarterly Report|March 10, 2017
Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015Genevieve M Klug, Alison Boyd, Shannon Sarros, et al.Circulation|June 11, 1975
Ventricular function before and after direct revascularization surgery. A proposal for an index of vascularization to correlate angiographic and ventriculographic findingsJ A Levine, D J Bechtel, P F Cohn, et al.Journal of Inorganic Biochemistry|February 9, 2006
High-valent iron complexes with tetraamido macrocyclic ligands: structures, Mössbauer spectroscopy, and DFT calculationsArani Chanda, Delia-Laura Popescu, Filipe Tiago de Oliveira, et al.American Journal of Nephrology|July 23, 2013
Predictors of provider-patient visit frequency during hemodialysisYelena Slinin, Haifeng Guo, Suying Li, et al.Journal of Neuropathology and Experimental Neurology|November 18, 2009
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infectionVictoria Lewis, Andrew F Hill, Cathryn L Haigh, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
A comparative study of intravenous versus intralymphatic interleukin-2, with assessment of effects of interleukin-2 on both peripheral blood and thoracic-duct lymphG Sarna, H Machleder, J Collins, et al.Pageof 372